Cancer-Testis Antigen Lymphocyte Antigen 6 Complex Locus K Is a Serologic Biomarker and a Therapeutic Target for Lung and Esophageal Carcinomas
Nobuhisa Ishikawa(The University of Tokyo), Yataro Daigo(The University of Tokyo), Hitoshi Nishimura(Tokushima University), Hiroyuki Ito(Kanagawa Prefectural Hospital Organization), Wataru Yasui(Hiroshima University), Eiju Tsuchiya(Kanagawa Prefectural Hospital Organization), Yohei Miyagi(Kanagawa Cancer Center), Masahiro Fujita(Keiyukai Sapporo Hospital), Atsushi Takano(The University of Tokyo), Yusuke Nakamura(Rissho University), Masao Hosokawa(Keiyukai Sapporo Hospital), Haruhiko Nakayama, Kouki Inai(Hiroshima University), Nobuoki Kohno(Hiroshima University)
Cited by 125
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804